首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Blood

缩写:BLOOD

ISSN:0006-4971

e-ISSN:1528-0020

IF/分区:23.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引21782
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yanfang Peipei Zhu,Sergio D Catz,Ben A Croker Yanfang Peipei Zhu
Neutrophils are acute responders to bacterial and fungal infection; however, their roles in disease extend far beyond their critical roles in countering pathogens. In this review, we seek to provide some broader context based on recent lite...
Katherine C Wood,Seyed Mehdi Nouraie,Mark T Gladwin et al. Katherine C Wood et al.
Sickle cell disease attenuates nitric oxide signaling, limiting soluble guanylyl cyclase (sGC) stimulation needed for hemo-vascular function. Cytochrome b5 reductase 3 (CYB5R3) regulates sGC activity and expression. We show CYB5R3 T117S ass...
Hitomi Hosoya,Arash Velayati,Danai Dima et al. Hitomi Hosoya et al.
The impact of chimeric antigen receptor (CAR)-T cell expansion and persistence on clinical outcomes and treatment-related morbidity in patients with relapsed/refractory multiple myeloma (RRMM) remains incompletely defined, in part due to li...
Sarah Bröchtel,Constanze Schneider,Marius Müller et al. Sarah Bröchtel et al.
Patients with acute leukemias harboring translocations involving gene lysine methyltransferase 2A (KMT2A) have a poor prognosis due to chemotherapy resistance with rapid relapse following standard treatments. The resulting KMT2A fusion prot...
Andrew A Lane,Marlise R Luskin,Julia H Keating et al. Andrew A Lane et al.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an orphan, aggressive hematologic malignancy characterized by high CD123 expression. Tagraxofusp (TAG), a CD123-directed toxin, is the only approved therapy. Prior studies demonstrated...
Sham Mailankody,Sneha Mitra,Kevin Herrera et al. Sham Mailankody et al.
BCMA and GPRC5D-directed therapies have shown high efficacy in the treatment of relapsed or refractory myeloma with multiple new immune therapies now approved. Preclinical studies have shown that expression of BCMA and GPRC5D are heterogeno...